Investors seeking to outperform the market often focus on hand-picking stocks. Selecting the right ones has proven to be a key factor in boosting wealth.
The price of Allogene Therapeutics Inc (NASDAQ: ALLO) closed at $1.55 in the last session, down -0.64% from day before closing price of $1.56. In other words, the price has decreased by -$0.64 from its previous closing price. On the day, 2.01 million shares were traded. ALLO stock price reached its highest trading level at $1.69 during the session, while it also had its lowest trading level at $1.51.
Ratios:
We take a closer look at ALLO’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 8.54 and its Current Ratio is at 8.54. In the meantime, Its Debt-to-Equity ratio is 0.21 whereas as Long-Term Debt/Eq ratio is at 0.20.
On May 31, 2024, Piper Sandler started tracking the stock assigning a Overweight rating and target price of $11.Piper Sandler initiated its Overweight rating on May 31, 2024, with a $11 target price.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Mar 14 ’25 when Chang David D sold 46,668 shares for $1.96 per share. The transaction valued at 91,469 led to the insider holds 5,276,569 shares of the business.
Beneski Benjamin Machinas sold 5,488 shares of ALLO for $10,839 on Mar 14 ’25. The SVP, Chief Technical Officer now owns 218,507 shares after completing the transaction at $1.98 per share. On Mar 14 ’25, another insider, Beneski Benjamin Machinas, who serves as the Officer of the company, bought 5,488 shares for $1.97 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ALLO now has a Market Capitalization of 336760736 and an Enterprise Value of 135040336. For the stock, the TTM Price-to-Sale (P/S) ratio is 16838.00 while its Price-to-Book (P/B) ratio in mrq is 0.78. Its current Enterprise Value per Revenue stands at 6138.197 whereas that against EBITDA is -0.554.
Stock Price History:
The Beta on a monthly basis for ALLO is 0.96, which has changed by -0.64611876 over the last 52 weeks, in comparison to a change of 0.06429911 over the same period for the S&P500. Over the past 52 weeks, ALLO has reached a high of $4.57, while it has fallen to a 52-week low of $1.32. The 50-Day Moving Average of the stock is -16.33%, while the 200-Day Moving Average is calculated to be -34.28%.
Shares Statistics:
According to the various share statistics, ALLO traded on average about 5.50M shares per day over the past 3-months and 3607550 shares per day over the past 10 days. A total of 212.21M shares are outstanding, with a floating share count of 139.53M. Insiders hold about 35.78% of the company’s shares, while institutions hold 63.64% stake in the company. Shares short for ALLO as of 1741910400 were 38012142 with a Short Ratio of 6.91, compared to 1739491200 on 33662897. Therefore, it implies a Short% of Shares Outstanding of 38012142 and a Short% of Float of 24.260001.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
